Notices and Reminders
Subrecipient Intent Documents
When an outside entity is completing programmatic work on an OUHSC grant application, a subrecipient intent form is required along with a scope of work, budget, budget justification, and other proposal documents as necessary. This intent to enter into a collaboration with OUHSC must be signed by an Authorized Official of the outside entity. It is OUHSC’s responsibility as the prime institution to have documentation that the outside entity has officially approved the proposed collaboration before we propose the collaboration to the sponsor. Some sponsors (such as NIH) require this documentation as part of the application. However, even if the sponsor does not have a requirement for these documents to be submitted with the application, it is an OUHSC requirement to have these documents as part of the review process. Subrecipient intent documents must be received by the three-day ORA review deadline or a waiver request form must be submitted to the Associate Vice President for Research Administration via email.
IMPORTANT UPDATE FROM THE IRB OFFICE: Revised IRB Application Coming March 26th
The IRB will publish a revised HSC Application in iRIS on Tuesday, March 26th. This change will impact ALL studies using the HSC Application.
Please review the summary of changes in advance to prepare for updating your applications. New and current applications submitted for IRB review will be returned for correction if all of the changes have not been addressed. Help us help you avoid delays in submission processing!
Please contact the HSC IRB Office if you have any questions or need more information. Thank you.
Ph: 405-271-2045
Email: irb@ouhsc.edu
LIBRARY RESOURCES: Please find a list of resources the Robert M. Bird Library has to offer attached to this email. Web:
http://library.ouhsc.edu/ and Twitter: @ouhsclibrary
NIH Guidance on Communicating and Acknowledging Federal Funding
Recipients should only acknowledge NIH awards on publications and other statements when the activities that contributed to that publication
1) directly arise from the award;
and 2) are within the
scope of the award being acknowledged. When considering whether acknowledgement is necessary, ask yourself:
-
Did the personnel activity supported by the award contribute to the publication?
-
Did the award support the conduct of experiments or the analysis of data that contributed to the publication?
-
Is there a clear and apparent link between the work described in the publication with the aims and objectives of the grant?
If the answer is yes to any of these questions, cite the appropriate NIH support.
Each publication, press release, or other document about research supported by an NIH grant must include:
-
An acknowledgment of NIH grant support such as: "Research reported in this [publication, release] was supported by [name of the Institute, Center, or other funding component] of the National Institutes of Health under grant number [specific NIH grant number in this format: R01GM012345]."
-
A disclaimer that says: "The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."
NIH requires recipients to adhere to the requirements of the Steven's Amendment
Public Law 101-166, Section 511, which states that HHS recipients must acknowledge Federal funding when issuing statements, press releases, requests for proposals, bid invitations, and other documents describing projects or programs funded in whole or in part with Federal money. Recipients are required to state 1) the percentage and dollar amounts of the total program or project costs financed with Federal money and (2) the dollar amount of the total costs financed by nongovernmental sources, only for NIH programs that require cost-sharing (NIH GPS 4.2.1).
NIH Guidance on Marking Changes in Resubmission Applications
Notice Number: NOT-OD-24-061
This Notice informs the applicant community that, effective May 25, 2024, this guidance replaces previous guidance on marking changes in Resubmission applications. The use of markups such as bracketing, indenting, highlighting, bolding, italicizing, underlining, margin lines, change in typography, font, or font color, or any other type of markup should not be used to identify changes in Resubmission applications.
Changes made to a Resubmission application should only be outlined in the Introduction attachment. The Introduction must include a summary of substantial additions, deletions, and changes to the application. It must also include a response to weaknesses raised in the Summary Statement. Unless otherwise indicated in the Table of Page Limits, the Introduction may not exceed one page.
Marketing and Communication Process for Research Activities
OU Health Sciences now has a dedicated marketing and communications team, including a writer who publicizes research activities across campus. If you have research news, please email April Wilkerson at
April-J-Wilkerson@ouhsc.edu or call extension 33182. Newly awarded grants, recent publications, national awards, public service and community outreach activities are among the potentially newsworthy items. If possible, please notify April as early as possible about upcoming publications.
OUHSC Editing and Grant Writing Support: The VPR office will be hiring an in house editor that has vast experience in editing and writing manuscripts and grant proposals, but will not be on board until late spring. In the interim, there is also a service of freelancers that can help in this regard. The editing, writing services provided by
Eloquenti has extended to us at the University of Oklahoma Health Sciences an opportunity to receive scientific editing and grant writing support at a discounted rate. Eloquenti is a network of professional editors and grant writers specializing in medicine and natural sciences, trusted by numerous universities, research institutes, and peer-reviewed journals. To benefit from this offer, simply use the code
OUHSC23 when booking any project on Eloquenti, which is a marketplace of freelancers and scientific experts for proofreading services, copy editing services, technical writing, grant writing, and book writing.
Please use the vendor id 9100091739 and each department will be responsible for payment by entering a requisition to receive a purchase order through purchasing.
Workshops and Seminars
2024 Oklahoma Geroscience Symposium
April 11, 2024 | Nicholson Conference Center, OKC
The Oklahoma Nathan Shock Center of Excellence is proud to host the
2024 OKLAHOMA GEROSCIENCE SYMPOSIUM: Mitochondria in aging and age-associated disease. The symposium will feature a Keynote Lecture by Doug Wallace, PhD and other world-renowned speakers in aging and Geroscience research, a Funders’ Roundtable, Poster Session, and Trainee/Faculty Mixer.
2024 Web of Life Conference
Date: 4/25/2024 - 4/26/2024
Location: Nicholson Auditorium, 1000 NE 13th St, Oklahoma City, OK 73104
Description: Major diseases such as cancer, cardiovascular disorders, diabetes, obesity, aging, and neurodegeneration are often studied and treated in isolation. Yet, each of them may be related, causally or otherwise, to one another. Therefore, facilitating crosstalk among these is expected to foster multidisciplinary collaboration and drive innovative and effective solutions.
The two-day Web of Life Conference will be hosted for the first time by the University of Oklahoma Health Sciences Center in April 2024. To realize the full potential of team science, we are bringing stalwarts from disparate yet connected fields such as cancer, diabetes, ageing bioengineering, and neurodegeneration to unite them under the common theme - “Web of Life: Connecting the Dots.” This collaboration will significantly impact and improve the way we engage communities, treat patients, foster collaboration, and facilitate groundbreaking discoveries.
OUHSC Funding Opportunities
Center for Indigenous Resilience, Culture, and Maternal Health Equity (CIRCLE) Request for Letters of Intent: Pilot Projects
Description: The CIRCLE Pilot Projects program seeks to support novel clinical and translational ideas that impact the understanding and solution of Indigenous maternal mortality and morbidity (MMM) or maternal health disparities. This program will support proposals designed to generate preliminary data that enhances the competitiveness of the investigators for extramural funding while furthering our understanding of MMM to improve maternal health outcomes for Indigenous mothers in Oklahoma and the Southern Plains. CIRCLE plans to fund up to 4 pilot projects in 2024 for up to $25,000 each.
Deadline for Letters of Intent: May 1, 2024
Link to the Full Announcement: Please see attached (CIRCLE pilot project application 2024)
Geroscience T32 Positions Available Graduate Students and Post-doctoral Fellows
The Geroscience T32 NIH training program has been funded since 2017 and currently supports 3 post-doctoral fellows and 5 graduate students with research interests in the field of geroscience. The goal of the program is to offer training and mentorship to young investigators
to significantly advance their careers. The program focuses on the interaction between biological aging and disease (aging as a risk factor for disease). These areas include, but are not limited to, mechanisms of brain aging (including Alzheimer’s Disease), neurodegeneration, cellular senescence, neuronal glycolysis, caloric restriction, oxidative stress, molecular biology of aging, mitochondria dysfunction, genomics, metabolomics, immune function, sarcopenia and gero-oncology.
We anticipate 1 post-doctoral position, and 1-2 graduate positions will be open in the summer of 2024.
Send Applications to (william-sonntag@ouhsc.edu & melissa-k-day@ouhsc.edu) as a single pdf file with your last and first names.Applications are due Friday March 29, 2024 at 5:00pm.
Investigator Initiated Trials Funding Committee (IITFC), Clinical Trials Office-Protocol Support Unit
Description: Grant proposals are being accepted for the
2024 Spring cycle from
Stephenson Cancer Center Providers for their investigator-initiated clinical trials (IITs) or translational work for the amount of up to $100,000 for clinical trials, and up to $25,000 for translation research. All applications should be submitted to the Protocol Support Unit at
SCC-IIT-Office@ouhsc.edu and should adhere to the
Grant template and
Submission Checklist provided with this notice.
Investigators should request the budget template from the CTO Budget Manager (ClinicalTrialBudgets@ouhsc.edu) and seek Statistician support at https://redcap.ouhsc.edu/redcap/surveys/?s=HWX4XPMELM. Deadline: April 15th, 2024 at 5 pm CST
Link to the full announcement or a flier: Please refer to the attached flyer for additional funding criteria and details.
Presbyterian Health Foundation (PHF) Technology Advancement Grant (TAG) Program – Request For Applications
The TAG program replaces the Equipment grant program. The primary objective of the PHF TAG program is to provide partial funding for critically needed research equipment that could be transformative for the research mission at OUHSC. This program is fully aligned with Pillar 1 of the Strategic Plan. The TAG program will proactively and with the help of a committee address campus-wide needs and fill critical gaps, with the goals to grow the research enterprise, expand innovative technology and research infrastructure, and promote addition of new cutting-edge technology on campus. Funding priority will be given to research equipment that will permit OUHSC investigators to be more competitive for external funding and provides support to multiple users. Funds may be used for equipment to be purchased as part of a recruitment package for new faculty or for equipment to support the research of current faculty. If the funds will be used for a new recruit, the recruit must have signed the offer letter with a specific start date or specific start date time frame. Equipment and/or technology funded by PHF is expected to be made available to all researchers at OUHSC, whenever possible.
All OUHSC Assistant, Associate, or Full Professors are eligible to apply. Applicants are required to match requested funds. The maximum allowable budget for this program is $500,000 (PHF funding: $250,000; Applicant funding: $250,000). The minimum allowable budget for this program is $60,000 (PHF funding: $30,000; Applicant funding: $30,000). Only one application will be accepted per investigator per year.
Presbyterian Health Foundation (PHF) Bridge Grant Program – Request For Applications
The primary objective of the PHF Bridge Grant Program is to provide funding to enhance OUHSC faculty competitiveness for extramural funding. OUHSC Principal Investigators are eligible if they meet the following criteria: 1) have submitted an extramural application within the past 18 months that was scored but not funded, 2) are requesting over $750,000 in total direct costs and over $200,000 in total facilities and administration (F&A) costs; and 3) received a review that ranks applications and provides critiques.
Presbyterian Health Foundation (PHF) Clinical Translational Grant Award (CTGA) Program – Request For Applications
The CTGA program will replace the Team Science program. The primary objective of this PHF CTGA mechanism is to grow collaborations and expand innovative healthcare research activities and promote collaboration among faculty to help OUHSC achieve the goals outlined in Pillar 1 of the Strategic Plan. The investigators must consist of one basic science researcher and one clinician researcher who can develop a broadly based, multidisciplinary research program focused on a specific disease entity, biomedical problem area, or clinically relevant problem. The proposal must focus on the collaborative relationship, such that the scientific objectives could not be achieved without the efforts of a basic science researcher, a clinician researcher, and their respective expertise and/or disciplines. It is expected that both members of the investigator team will devote an equivalent amount of effort to the project (60/40 or 50/50 distribution of effort).
The funding for this program can be for up to two years. The second year of funding, if funds are available, will be based on successful achievement of identified milestones as noted by the researchers in the Year 1 application and quality of specified milestones to be met during the next year of funding, as documented in the completed Year Two application form.
This funding opportunity is intended to:
-
Promote collaborative scientific interactions among investigators
-
Support translation of novel basic/pre-clinical observations or the translation, dissemination, and implementation of clinical observations to community settings
-
Foster engagement of interdisciplinary teams
-
Support collaborative interactions among clinical and fundamental research investigators leading to co-authored papers and grant applications.
PHF CTGA awardees may hold PHF Symposium grants, Technology Advancement Grants (TAG), or Bridge grants throughout the duration of this award, but may not serve as the Contact PI/Team Leader on more than one PHF Clinical Translational Grant. A single investigator may only be awarded one CTGA award at a time, whether as contact PI or collaborating PI.
College of Medicine Research Fund
Proposals are being accepted from full-time faculty of the College of Medicine for grants to be awarded from the College of Medicine Alumni Association with proceeds generated from the Evening of Excellence dinner fund. COMAA awards are intended to be an important resource for funding basic and clinical research projects of new and early-stage investigators in the College of Medicine. The guidelines are attached. Successful applicants will be designated “College of Medicine Alumni Research Scholars.” Applications will be reviewed by a scientific panel whose composition will be based on the types of applications received. Awards generally fall within the $20,000 to $50,000 range ($50,000 maximum request).
Office of Technology Commercialization presents the following opportunity for Office of Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click
here for more information, or email
otc@ou.edu or
gina-mcmillen@ouhsc.edu).
LifeArc, a non-profit medical research organization, is seeking innovative proposals to boost drug repurposing in motor neuron disease. Approaches of interest include preclinical stage research with a repurposed drug or drug combination. Submission of an Expression of Interest form is required as part of the application process; more information can be found at the
LifeArc – Drug Repurposing in MND. Deadline May 10th.
NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted). The letters of intent will be reviewed and a single application will be chosen for submission from the University.
NIH Funding Opportunities